In this article, we are going to take a look at where Apogee Therapeutics, Inc. (NASDAQ:APGE) stands against the other small-cap stocks. The S&P 500 index has reached its all-time highs ...

In a small sign of a possible improvement in the sluggish biotech initial public offering (IPO) market, Apogee Therapeutics has said it expects gross proceeds of $300 million from its Nasdaq ...

Sidereal Confluence: Trading and Negotiation in the Elysian Quadrant was one of the most intriguing releases of 2017, a heady mix of trading and diplomacy between alien factions in deep space that was ...